Metropolis’s to train future doctors in Immunohistochemistry

Metropolis Healthcare Ltd. through its interactive medical education initiative, Metrospheres has started a unique experience based learning program in Immunohistochemistry (IHC) aimed at creating industry ready doctors and medical practitioners. Through this, Metropolis is preparing special hands on training PG students (MD / DNB Pathology) & Practicing Pathologists with a focus on better patient outcomes and treatment in oncology, through trained, pathologists, IHC is an invaluable tool in the correct recognition of tumors. It is now being increasingly used for prognosis of tumors and as an initiation of expensive targeted therapy in oncology practice for prediction of response to treatment.

The training programme includes in-depth theory and extensive hands - on experience in IHC techniques. Oncology is a practice where wrong diagnosis can lead to severe consequences for the patient.Metropolis aims to create a better understanding of this complex subject and troubleshoot problems in Oncosurgical Pathology & Oncohematology.

Dr. Kirti Chadha, National Coordinator & HOD, Surgical Pathology said “At Metropolis, we have made it a routine practice to provide an accurate diagnosis using all available tests to each one of our patients & with this initiative we have created a platform to bring together practicing & training pathologists. We are using molecular morphology of IHC and tissue to set the stage for treatment. IHC is far more powerful than it was two or three decades ago.”